SEROBA HEALTH CAPITAL MANAGEMENT LIMITED

Seroba Health Capital Management Ltd – operating under the Seroba Lifesciences brand – is a European venture‑capital firm specialising in life‑science investments. The firm creates value by backing high‑impact innovations in biotechnology and medical‑technology, supporting entrepreneurs who are developing breakthrough therapies and devices. Its portfolio includes companies such as Perfuze, which is advancing next‑generation stroke‑treatment catheters, and Complement Therapeutics, which is progressing a gene‑therapy programme for complement‑mediated diseases.

Seroba’s team combines deep investment expertise with operational experience in the sector, offering strategic guidance, capital and network access to help start‑ups scale into world‑class businesses. The firm serves early‑stage biotech and medtech companies, as well as institutional investors seeking exposure to cutting‑edge health‑care innovation. By partnering with founders and leveraging its European reach, Seroba aims to deliver both financial returns and tangible health‑impact.